A tosylate salt of Sorafenib which is a kinase inhibitor drug. It is used for the treatment of kidney, liver and thyroid cancer. It works by inhibiting the VEGFR-2/PDGFR-beta signaling cascade, thereby blocking tumor angiogenesis. Reference standards of Sorafenib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Sorafenib-d3 [catalogue_number] => PA STI 079660 [category_ids] => ,81,98,78,70,82, [chemical_name] => [weight] => 467.84 [form] => C21H13D3ClF3N4O3 [cas] => 1130115-44-4 [pslug] => 1130115-44-4-sorafenib-d3-pasti079660 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA STI 079660
CAS :
Molecular Formula : C21H13D3ClF3N4O3
Molecular Weight : 467.84
stdClass Object ( [pname] => Sorafenib-13C,d3 [catalogue_number] => PA STI 079661 [category_ids] => ,98, [chemical_name] => [weight] => 468.84 [form] => C2013CH13D3ClF3N4O3 [cas] => 1210608-86-8 [pslug] => 1210608-86-8-sorafenib-13c-d3-pasti079661 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA STI 079661
Molecular Formula : C2013CH13D3ClF3N4O3
Molecular Weight : 468.84
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
